| Literature DB >> 9374389 |
J D Howell1, C S McArdle, D J Kerr, J Buckles, J A Ledermann, I Taylor, H J Gallagher, J Budden.
Abstract
Forty patients with unresectable colorectal metastases confined to the liver were evaluated in a phase II study. 5-Fluorouracil (5-FU) was delivered via a surgically placed hepatic artery catheter. Patients received folinic acid (200 mg m-2) intravenously over 2 h followed by a loading dose of intra-arterial 5-FU (400 mg m-2) over 15 min, then 5-FU (1600 mg m-2) by intra-arterial infusion over the following 22 h. This was repeated on day 2 and the whole schedule was repeated every 2 weeks. Response was assessed after six treatments. The median follow-up was 17 months. Overall response rate was 46% with 8% complete response. Estimated median survival is 19 months. Site of progression was the liver alone in 55%, liver and lung in another 16% and 29% in other sites. Eight patients experienced grade 3 or 4 toxicity. The response rate of this regimen compares favourably with reported trials of intra-arterial FUDR, and our schedule is currently being compared with a similar schedule of intravenous 5-FU and folinic acid in a randomized Medical Research Council trial (CR05).Entities:
Mesh：
Substances：
Year: 1997 PMID： 9374389 PMCID： PMC2228150 DOI： 10.1038/bjc.1997.566
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640